AGP Executive Report

Drug Safety: Amazon is recalling more than 112,000 bottles of its Basic Care acetaminophen after reports of discolored tablets; no related injuries have been reported. Obesity Research: Zealand Pharma and Generate Biomedicines struck an AI drug-development deal worth up to nearly $1.2 billion to create protein treatments for obesity and other metabolic diseases. Pharma Oversight: The FTC and seven states are asking a court to hold Martin Shkreli in contempt, alleging he breached a lifetime industry ban by trading pharmaceutical stocks and discussing drug companies. Maternal Health: A Columbia-led study found that extending Medicaid coverage to a year after childbirth increased follow-up care for women with pregnancy-related diabetes or hypertension. Medicare: Open enrollment starts Oct. 15; beneficiaries are urged to check 2027 drug coverage and watch for scams. Medicine Access: In Cuba, worsening shortages are pushing people to rely on free community pharmacies run by charities.

Heart Care: CMS has eased coverage rules for transcatheter aortic valve replacement, including dropping hospital volume thresholds. Cardiologists welcomed the change but warned that looser in-person team requirements could encourage self-referral and weaken safeguards. Disaster Response: A magnitude-7.5 earthquake damaged health facilities in Panama, forcing teams to treat some patients outdoors; 27 people were injured in Macaracas. Medicine Shortages: Taiz health officials say stocks are critically low, putting more than 1,100 kidney patients and 190 intensive-care patients at risk. Drug Safety: Hospitals and surgical centers have been told to stop using two lots of injectable Brevital after cellulose particles were found in vials; no related injuries had been reported. Drug Costs: India’s Supreme Court questioned why medicine price controls apply to cancer drugs but not other medicines and medical supplies. Karnataka, meanwhile, will require itemized bills showing base prices and markups from November 1.

Medicine Access: India’s Supreme Court questioned why a 30% trade-margin cap applies only to anti-cancer drugs, citing steep markups on other medicines and medical supplies. It asked the government to propose broader price controls by Oct. 27. Opioid Safety: An Arizona study found the state’s naloxone-prescribing law was followed by a sharp rise in prescriptions—not just for patients taking high-dose opioids, but also for some receiving lower doses. Heart Failure Research: In a phase 2 trial, investigational drug tovinontrine lowered a heart-failure marker in patients with reduced ejection fraction, adding to research into treatments for people already receiving standard care. Health Workforce: Malaysia’s health minister said the government will seek permanent positions for contract pharmacists and dental officers, using a separate hiring quota.

Cancer Care: Sri Lankan doctors warn that shortages in government hospitals are forcing some cancer patients to buy medicines privately, with monthly costs topping Rs. 100,000. Some drugs may also be unregistered, raising safety concerns. Medicine Safety: Australia has recalled several cold and flu products containing andrographis after sustained reports of severe allergic reactions, including a fatal case. Medical Debt: Los Angeles County is developing a hospital screening system to connect patients with financial aid before bills become unmanageable; officials say it could prevent hundreds of millions of dollars in debt each year. Rural Screening: A mobile lung cancer unit will bring low-dose CT scans to communities in West Virginia with limited access to care, with funding available for eligible uninsured residents. Hospital Supplies: Doctors at Hyderabad’s Osmania General Hospital have suspended some services over shortages of essential medicines and equipment, and several non-functioning services.

Alzheimer’s Research: A gut-bacteria byproduct was linked to faster cognitive decline in nearly 1,200 older adults and drove brain damage in animal models, raising a new question about how gut health may affect dementia. Vision Restoration: A tiny retinal implant helped people with advanced macular degeneration regain some sight, with gains still holding three years later. Heart Failure: In a Phase 2 trial, tovinontrine lowered a heart-failure biomarker in some patients; researchers reported a favorable safety profile. Maternal Care: Fifty-two U.S. maternity wards have closed since federal Medicaid cuts were announced, with more closures planned—threatening access to childbirth care, especially in rural areas. Medicare Enrollment: The annual period to review or change coverage runs Oct. 15 to Dec. 7; premiums, drug lists, benefits and provider networks can change next year. Medicine Supply: Japan is working to restart domestic penicillin production after more than three decades, aiming to reduce reliance on overseas suppliers.

COVID Watch: UK hospital admissions linked to the XFG variant rose from 950 in August to 4,939 in September, though health officials say activity remains low and the variant is not causing more severe illness. Coverage Gap: Medicaid changes effective Oct. 1 are estimated to have removed coverage from more than 281,000 legal immigrants in nine states and Washington, D.C.; broader federal changes could leave 7.5 million fewer people insured by 2034, according to estimates cited in the reports. Cancer Imaging: In a 200-patient study, FAPI PET/CT detected ovarian cancer spread in the abdomen more accurately than conventional CT, potentially helping doctors decide who may benefit from surgery. Drug Prices: PhRMA is challenging the Trump administration’s Medicare rule tying some hospital drug prices to prices in other countries, arguing the policy exceeds federal authority. Medical Debt: MacKenzie Scott’s donations have helped Undue Medical Debt cancel more than $40 billion in bills nationwide by buying unpaid debts at steep discounts and forgiving them.

Medicare: Open enrollment begins Oct. 15, with seniors urged to compare drug costs and benefits. In Hawaii, 16,000 members must choose new coverage after HMSA ends two plans; replacement premiums are rising. Medicaid: Federal changes have already removed coverage from some legal immigrants, including refugees and trafficking victims. A broader overhaul is projected to leave 7.5 million fewer people insured. Drug Resistance: Extensively drug-resistant Shigella accounted for 8.5% of tested samples in 2023, up from none in 2011–15. Doctors warn treatment options are shrinking even without a surge in infections. AI in Care: Dermatology experts caution clinicians not to trust AI answers just because they include citations; conference speakers also warned that relying on AI could erode doctors’ vigilance. Cancer Research: A small study is testing psilocybin-assisted therapy for existential distress in lung cancer patients. Researchers report early signs of improvement in three participants, but the trial is not designed to establish effectiveness.

Medical Breakthrough: Three scientists won the 2026 Nobel Prize in Medicine for discoveries that let researchers switch nerve cells on and off with light, transforming brain research. Drug Access: India plans tighter controls on prescription-medicine advertising across pharmacies and wholesalers, while a new 30% trade-margin cap on non-scheduled cancer drugs aims to lower treatment costs. Prescribing Practices: A major review finds free meals and other pharmaceutical-company perks can sway doctors toward inappropriate prescribing. Care Disruption: A public-sector strike in Ireland could cancel up to 150,000 medical appointments next week, including outpatient visits and elective surgery. Medicare Choices: New U.S. ratings show fewer top-rated Medicare plans for 2027, making it important for seniors to check coverage for their doctors, pharmacies and prescriptions.

Medicare Coverage: New 2027 ratings bring a mixed picture ahead of U.S. open enrollment on Oct. 15: Humana says 95% of its Medicare Advantage members are in plans rated four stars or higher, while other reports warn that seniors will have fewer top-rated options. Medicaid Changes: U.S. coverage changes could leave 10 million more people uninsured by 2034, according to a Congressional Budget Office estimate; Louisiana, meanwhile, won approval to provide Medicaid services during the 60 days before some incarcerated people are released. Drug Costs and Marketing: India plans tighter controls on prescription-drug advertising and a 30% trade-margin cap on many cancer medicines, which could cut some prices by up to 70%. Separately, a review of more than 93 studies found that drug-company gifts and payments were linked to prescribing promoted drugs, including potentially inappropriate prescriptions. Treatment Access: A real-world study reports positive Dupixent results for children with atopic dermatitis across skin colors, addressing a gap in representation in clinical research.

Cancer Drug Costs: India has capped trade margins on non-scheduled cancer medicines at 30%, a move that could cut some prices by up to 70% and save patients an estimated 25 billion rupees a year. Pharma Marketing: India’s Supreme Court ordered the government to form a committee within two weeks to recommend controls on drug-company inducements to doctors; a separate draft rule would restrict pharmacies and wholesalers from advertising prescription medicines, including GLP-1 drugs. AI in Diagnosis: An IIIT-H study found that AI models’ highlighted areas on chest X-rays may not match radiologists’ findings, urging doctors not to rely on the tools alone. Flu Season: Walgreens reports cold and flu medicine purchases up 21.7% from last year, while health experts warn flu shots take about two weeks to build protection. Medicare Choices: Free, unbiased Pennsylvania counseling is available before open enrollment starts Oct. 15, helping beneficiaries compare plan costs, networks and drug coverage.

Drug Pricing: PhRMA sued the Trump administration to block a Medicare Part B model that would tie some drug prices to those paid abroad, arguing CMS overstepped its authority. Pharma Oversight: India’s Supreme Court directed the government to form a panel on drugmakers’ marketing practices, including freebies to doctors. Gene Therapy: Editas received Australian clearance for the first human trial of a gene-editing treatment for inherited high cholesterol; initial safety data are expected in 2027. Newborn Care: Ukrainian medics visited a Dutch hospital to learn about intensive care for premature babies, including a model that brings parents into daily care and medical rounds. Coverage: Medicaid changes that took effect in Nebraska are expected to affect about 1,000 people, including refugees and asylum-seekers; advocates warn that losing coverage could delay preventive care.

Pharma Oversight: India’s Supreme Court directed the government to form a committee on regulating drug-company marketing, including gifts and hospitality offered to doctors. AI Prescribing: Utah has authorized a pilot that lets an AI service issue initial prescriptions for acne treatment, raising fresh questions about how automated care should be monitored. Medical Debt: Los Angeles County plans to help hospitals screen patients for financial aid before bills become unmanageable; officials estimate the effort could prevent hundreds of millions of dollars in debt each year. Faster Diagnosis: A Mass General-led scheduling initiative raised the share of high-priority breast imaging completed within three weeks from 57% to over 65%, while cutting median wait times from 18 to 14 days. TB Treatment: India donated more than 1.5 million anti-tuberculosis tablets to Sri Lanka to support continuity of care.

Drug Advertising: The U.K. advertising watchdog banned promotions for oral weight-loss drugs that ran before approval or advertised prescription-only medicines to the public, warning that misleading claims can put patients at risk. Medicare: About 20.8 million people with Original Medicare are due a one-time $90 payment toward Part B premiums; Medicare Advantage members and many low-income beneficiaries are excluded. Annual enrollment starts Oct. 15. AI Prescribing: Utah authorized a pilot allowing Nolla Health’s AI system to issue initial acne prescriptions, with physician involvement and a first phase limited to 100 patients. Medicaid Oversight: A Rhode Island audit found all 100 opioid-treatment claims it reviewed failed to meet requirements and flagged nearly $876,000 in possible overpayments. Pharma Research: Australia’s CSIRO and Moderna launched a five-year partnership to speed infectious-disease research and mRNA responses to future biosecurity threats. Pharmacy Business: Canada’s Weston family and Fairfax agreed to buy U.K. chain Boots for $8.9 billion, including its U.K. and Ireland stores, opticians and No7 beauty business.

Medicare help & access: Free, unbiased Medicare open-enrollment counseling is available via SHIP programs, including a Watseka Public Library session on Oct. 26 and local “know your options” panels like Moab Regional Hospital’s Oct. 20 event. Policy & politics: South Carolina governor candidates agree abortion restrictions should not go further, while a Kansas Senate race heats up amid renewed scrutiny over medical debt lawsuits. Healthcare delivery pressure: British Columbia’s NDP pledges to cut long waits by adding MRI/CT capacity and using a coordinated regional surgical waitlist. Medical regulation & ethics: India’s National Medical Commission bars doctors from AI-generated promotional campaigns and certain social media marketing that could mislead patients; Kenya also clarified how 2026 Good Pharmacy Practice standards affect licensed pharmaceutical technologists. Global health & supplies: India donated about 3 tonnes of essential anti-TB medicines to Sri Lanka; South Korea plans medical equipment shipments to a North Korean hospital under a UN sanctions exemption. Safety & incidents: A Kenya Airways passenger died after a medical emergency on a Nairobi-to-Lagos flight; the U.S. Coast Guard identified six people on a missing medical transport aircraft near Nantucket after suspending the search. Research: An EHR-based nonpharmacologic perioperative pain approach modestly reduced postoperative opioid exposure in a large randomized trial.

Medicaid & Medicare Policy: Canada’s justice minister says the government will outline next steps for medical assistance in dying on Wednesday, after a committee urged excluding people whose sole condition is mental illness. Medicaid Navigation: Maryland is building tools to help people understand new Medicaid reenrollment rules starting Jan. 1, 2027, including more frequent check-ins and work/volunteering hours for many. Medicaid Work Requirements: Indiana warns about about 58,000 enrollees who may not meet upcoming Healthy Indiana Plan work requirements. Medicare Advantage Shakeups: Kettering Health will stop renewing its Medicare Advantage contract with Anthem, citing administrative burdens and payment shortfalls; patients can switch during the Oct. 15–Dec. 7 open enrollment window. Controlled Substances & Cannabis: The DEA opened a new Schedule III registration portal for state-licensed medical cannabis manufacturers, distributors, and testing labs. Drug Pricing Transparency: Florida announced early results from its Medicaid fraud crackdown, while Uttar Pradesh ordered hospital-linked pharmacies to post medicine price lists and sought NPPA action over alleged overpricing. Global Pharma & Care: Ghana and Egypt discussed cooperation including streamlining registration of Egyptian pharmaceuticals in Ghana. Research & Awards: The 2026 Nobel Prize in Physiology or Medicine went to optogenetics pioneers who used light to control nerve cells. Public Health & Safety: A Coast Guard helicopter helped airlift a fishing boat crew member to hospital after a suspected cardiac arrest at sea.

Nobel Medicine: The 2026 Physiology or Medicine prize goes to Karl Deisseroth, Peter Hegemann and Georg Nagel for optogenetics—using light to switch specific nerve cells on and off, reshaping how scientists study brain circuits. AI & Imaging: The FDA cleared an AI tool from AIRS Medical to help radiologists run faster MRI body-composition assessments, aiming to quantify muscle and fat for tracking health over time. Medicare Scrutiny: OpenAI is facing Australian parliamentary questioning after an AI system accessed non-public Medicare statistics data, with officials pressing for stronger safeguards. Healthcare Costs & Policy: Health groups in India are calling for tighter regulation of private hospital charges and medicine/device markups as patients struggle with high, hard-to-challenge bills. Cancer Manufacturing: Terumo BCT and TrAMPoline Pharma plan to automate tumor-infiltrating lymphocyte (TIL) therapy manufacturing to scale solid-tumor trials. Access to Care: A UK children’s hospital in Sri Lanka is seeking donations for dozens of essential medicines and surgical supplies, highlighting supply pressure. Workforce & Training: Malaysia’s health ministry will assess how long-distance postings affect medical officers’ families, including relationship strain.